OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.         )*

Medical Discoveries, Inc.


(Name of Issuer)

Common Stock


(Title of Class of Securities)

58456E


(Cusip Number)

October 29, 2003


(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        o Rule 13d-1 (b)

        x Rule 13d-1 (c)

        o Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

Page 1 of 5 pages


 

             
13G
CUSIP No. 58456E Page 2 of 5

  1. Name of Reporting Person:
Judy M. Robinett
I.R.S. Identification Nos. of above persons (entities only):

  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) o  

  3. SEC Use Only:

  4. Citizenship or Place of Organization:
United States of America

Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
16,030,000

6. Shared Voting Power:
0

7. Sole Dispositive Power:
16,030,000

8.Shared Dispositive Power:
0

  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
16,030,000

  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o

  11.Percent of Class Represented by Amount in Row (9):
22.4%

  12.Type of Reporting Person:
IN

Page 2 of 5 pages


 

Item 1. Issuer

  (a)   The name of the Issuer is Medical Discoveries, Inc.

  (b)   The Issuer’s executive offices are located at 738 Aspenwood Lane, Twin Falls, Idaho 83301.

Item 2. Reporting Person and Security

  (a)   This Statement is filed by Ms. Judy M. Robinett, an individual.

  (b)   Ms. Robinett’s business address is 738 Aspenwood Lane, Twin Falls, Idaho 83301.

  (c)   Ms. Robinett is a citizen of the United States of America.

  (d)   This Statement relates to shares of Common Stock of Medical Discoveries, Inc.

  (e)   The CUSIP number assigned to the Common Stock of the Issuer is 58456E.

Item 3. Filings Pursuant to Rule 13d-1(b) or 13d-2(b) or (c)

  (a)   / / Broker of dealer registered under Section 15 of the Exchange Act;

  (b)   / / Bank as defined in section 3(a)(6) of the Exchange Act;

  (c)   / / Insurance company as defined in section 3(a)(19) of the Exchange Act;

  (d)   / / Investment company registered under section 8 of the Investment Company Act of 1940;

  (e)   / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

  (f)   / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

  (g)   / / A parent holding company or control person, in accordance with Rule 13d-1(b)(ii)(G);

  (h)   / / A savings association, as defined in Section 3(b) of the Federal Deposit Insurance Act;

  (i)   / / A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

  (j)   / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

Page 3 of 5 pages


 

Item 4. Ownership

     (a) Under the rules and regulations of the Securities and Exchange Commission, Ms. Robinett may be deemed to be the beneficial owner of a total of 16,030,000 shares of Issuer Common Stock. This amount includes 16,000,000 shares subject to options that are currently exercisable or become exercisable within 60 days of November 5, 2003.

     (b) Ms. Robinett’s beneficial ownership of Issuer Common Stock represented approximately 22.4% of the Issuer’s issued and outstanding shares on November 5, 2003. For the purpose of computing the percentage of outstanding securities beneficially owned, the number of shares issued and outstanding is based on the amount known by Ms. Robinett to be issued and outstanding and includes those shares subject to Ms. Robinett’s options.

     (c) Ms. Robinett has sole power to vote or direct the voting and to dispose or to direct disposition of the outstanding shares that she beneficially owns.

Item 5. Ownership of Five Percent or Less of a Class

          Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person

          Not applicable.

Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

          Not applicable.

Item 8. Identification and Classification of Members of the Group

          Not applicable.

Item 9. Notice of Dissolution of Group

          Not applicable.

Item 10. Certification

          By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 4 of 5 pages


 

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    November 7, 2003
   
    Date
     
    /s/ JUDY M. ROBINETT
   
    Judy M. Robinett

Page 5 of 5 pages